Brief: Biocartis: 5 Idylla Performance Studies To Be Presented At Congress

Biocartis NV

23/09/2019 06:18

Sept 23 (Reuters) - BIOCARTIS GROUP NV  BCART.BR :
    * FIVE IDYLLA PERFORMANCE STUDIES TO BE PRESENTED AT ‘EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY’
CONGRESS
    * ALL STUDIES DEMONSTRATED EXCELLENT PERFORMANCE OF IDYLLA COMPARED TO OTHER METHODS, IN
COMBINATION WITH EASE OF USE AND FAST TURNAROUND TIME OF THE IDYLLA PLATFORM
    * LAUNCH OF FULLY AUTOMATED IDYLLA CTEGFR MUTATION ASSAY FOR LIQUID BIOPSY TESTING OF EGFR
MUTATIONS IS EXPECTED IN Q4 2019

Source text for Eikon:  ID:nGNE2f450M 
Further company coverage:  BCART.BR 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))